At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study
At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study
Acacia C Parks
1
, MBA, PhD ;
Amanda L Woodward
1
, MSc ;
Robert D Henry
2, 3
, PhD ;
Kristin A Arden
4
, APRN, PMHNP-BC, DNP ;
Leonardo Vando
4
, MD ;
Jack Swain
4
, MBA ;
Bishal Lamichhane
5
, PhD
1
Liquid Amber, Watertown, MA, United States
2
TSET Health Promotion Research Center, University of Oklahoma Health Sciences Center, Tulsa, OK, United States
3
Department of Biostatistics & Epidemiology, University of Oklahoma Health Sciences Center, Tulsa, OK, United States
4
Mindbloom, Orlando, FL, United States
5
Department of Psychiatry and Behavioral Health, Houston Methodist Academic Institute (HMAI), Houston Methodist, Houston, TX, United States